Crescenzi, B <br/><br/>
FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells.  [electronic resource] 

 -  Leukemia  Mar 2007 
 - 397-402 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2404510  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Antigens, CD--analysis<br/>Antigens, CD34--analysis<br/>Antineoplastic Agents--therapeutic use<br/>Benzamides<br/>Cell Lineage<br/>Chronic Disease<br/>Clone Cells--enzymology<br/>Drug Resistance<br/>Eosinophils--enzymology<br/>Erythrocytes--enzymology<br/>Fusion Proteins, bcr-abl--analysis<br/>Glycophorins--analysis<br/>Glycoproteins--analysis<br/>Granulocytes--enzymology<br/>Hematopoietic Stem Cells--enzymology<br/>Humans<br/>Hypereosinophilic Syndrome--drug therapy<br/>Imatinib Mesylate<br/>Immunophenotyping<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Lymphocyte Subsets--enzymology<br/>Megakaryocytes--enzymology<br/>Monocytes--enzymology<br/>Myeloid Cells--enzymology<br/>Neoplastic Stem Cells--enzymology<br/>Oncogene Proteins, Fusion--analysis<br/>Peptides--analysis<br/>Piperazines--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Receptor, Platelet-Derived Growth Factor alpha--analysis<br/>Tumor Stem Cell Assay<br/>X Chromosome Inactivation<br/>mRNA Cleavage and Polyadenylation Factors--analysis